Showing results (561-570 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|April 2, 2016
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 studyFrançois Bertucci, Mahmoud Fekih, Aurélie Autret, et al.
The Lancet. Oncology|August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trialDerek Alderson, David Cunningham, Matthew Nankivell, et al.
The Lancet. Oncology|August 14, 2017
Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation studyHema Sekhar, Marcel Zwahlen, Sven Trelle, et al.
The Lancet. Oncology|August 28, 2017
Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trialMeletios A Dimopoulos, Hartmut Goldschmidt, Ruben Niesvizky, et al.
The Lancet. Oncology|August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialHagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
The Lancet. Oncology|August 1, 2017
Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?Bennett E Levis, Phillip F Binkley, Charles L Shapiro
The Lancet. Oncology|June 25, 2016
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialDavid Dearnaley, Isabel Syndikus, Helen Mossop, et al.
The Lancet. Oncology|May 15, 2016
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 studyStephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
The Lancet. Oncology|May 18, 2016
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
The Lancet. Oncology|May 31, 2016
Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5Annalisa Trama, Laura Botta, Roberto Foschi, et al.
Pageof 336